Morning Briefing
Summaries of health policy coverage from major news organizations
House Panel Assails Fisher-Price For Ignoring Sleeper's Risks To Infants
Executives at Fisher-Price ignored repeated safety warnings about the company's once popular Rock 'n Play sleeper, even after infants began to roll over and die in the now-recalled product, according to a new report. An investigation by the House Committee on Oversight and Reform alleges that the New York-based children's products giant didn't adequately vet the sleeper for safety before putting it on the market in 2009 and then batted away criticism of the Rock 'n Play for a decade before recalling it in 2019 after more than 50 infants had lost their lives. "What we found is absolutely shocking," said the committee's chairwoman, Rep. Carolyn B. Maloney, D-N.Y. "It is a national scandal." (Hernandez, 6/7)
Two company executives were sharply criticized Monday by a House panel over Fisher-Price鈥檚 decision to keep its Rock 鈥檔 Play inclined sleeper on the market for a decade while waiting until 2019 to recall a product tied to dozens of infant deaths. Members of the House Oversight Committee seemed to struggle to find new ways to describe their outrage and incredulity with the well-known maker of toys and baby products, with Rep. Raja Krishnamoorthi (D-Ill.) saying Fisher-Price showed 鈥渁 shocking lack of corporate integrity.鈥 (Frankel, 6/7)
In other news from Capitol Hill 鈥
The U.S. Senate on Monday voted unanimously to pass legislation that would provide additional resources for American officials suffering from so-called "Havana Syndrome" 鈥 a mysterious set of symptoms that first affected federal employees stationed in Cuba in 2016. The bipartisan bill 鈥 Helping American Victims Afflicted by Neurological Attacks (HAVANA) Act 鈥 would authorize financial support for U.S. officials reporting symptoms related to the syndrome, including headaches, nausea, hearing and vision changes, vertigo and memory loss. (Wise, 6/7)